SCHEMBL12499757

SCHEMBL12499757

Nc1cc2c(Oc3ccc4c(ccn4C(=O)NC4CC4)c3)ccnc2cc1OCCCN1CCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 11/20 0.43
FLT1 P17948 5/20 0.43
FLT4 P35916 5/20 0.43
FGFR2 P21802 1/20 0.43
EHMT2 Q96KQ7 6/20 0.42
EHMT1 Q9H9B1 6/20 0.42
MET P08581 6/20 0.42
AURKA O14965 4/20 0.42
TEK Q02763 4/20 0.42
LCK P06239 3/20 0.42
AURKB Q96GD4 2/20 0.42
ABL1 P00519 1/20 0.42
LYN P07948 1/20 0.42
FGR P09769 1/20 0.42
AXL P30530 2/20 0.42
EGFR P00533 1/20 0.41
RET P07949 1/20 0.41
IGF1R P08069 1/20 0.41
KIT P10721 1/20 0.41
SRC P12931 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1894960 0.89 AXL (0.42) KDRFLT1FLT4FGFR2EHMT2
SCHEMBL13627390 0.88 KDR (0.49) KDRFLT1FLT4FGFR2MET
SCHEMBL12502130 0.88 FGFR2 (0.46) KDRFLT1FLT4FGFR2MET
SCHEMBL12503719 0.86 KDR (0.43) KDRFLT1FLT4FGFR2EHMT2
SCHEMBL1893505 0.80 KDR (0.63) KDRFLT1FLT4FGFR2MET
SCHEMBL1891567 0.78 FGFR2 (0.43) KDRFLT1FLT4FGFR2EHMT2
SCHEMBL1894317 0.78 KDR (0.67) KDRFLT1FLT4FGFR2MET
SCHEMBL1898319 0.78 FGFR2 (0.44) KDRFGFR2METAURKATEK
SCHEMBL1898322 0.78 FGFR2 (0.44) KDRFGFR2METAURKATEK
SCHEMBL3501428 0.77 FGFR2 (0.43) KDRFLT1FLT4FGFR2EHMT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973160-B2 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-07-05 US disclosed
US-20100197911-A1 Nitrogen-Containing Aromatic Derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-05 US disclosed
US-7612092-B2 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197911-A1 Nitrogen-Containing Aromatic Derivatives GNG2, GCG, FRG1 KDR 2687/4885FLT1 1368/4885FLT4 3144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.